Journal article

Dysregulated bone morphogenetic protein signaling in monocrotaline-induced pulmonary arterial hypertension


Authors listMorty, Rory E.; Nejman, Bozena; Kwapiszewska, Grazyna; Hecker, Matthias; Zakrzewicz, Anka; Kouri, Fotini M.; Peters, Dorothea M.; Dumitrascu, Rio; Seeger, Werner; Knaus, Petra; Schermuly, Ralph T.; Eickelberg, Oliver

Publication year2007

Pages1072-1078

JournalArteriosclerosis, Thrombosis, and Vascular Biology

Volume number27

Issue number5

ISSN1079-5642

eISSN1524-4636

DOI Linkhttps://doi.org/10.1161/ATVBAHA.107.141200

PublisherAmerican Heart Association


Abstract

Background - Mutations in the bmpr2 gene, encoding the type II bone morphogenetic protein (BMP) receptor, have been identified in patients with pulmonary arterial hypertension (PAH), implicating BMP signaling in PAH. The aim of this study was to assess BMP signaling and its physiological effects in a monocrotaline (MCT) model of PAH.

Methods and Results - Expression of BMP receptors Ib and II, and Smads 4, 5, 6, and 8, was downregulated in lungs but not kidneys of MCT-treated rats. Smad1 phosphorylation and expression of BMP/Smad target genes id1 and id3 was also reduced, although ERK1/2 and p38MAPK phosphorylation remained unaffected. BMP receptor and Smad expression, Smad1 phosphorylation, and induction of the BMP/Smad-responsive element of the id1 promoter were reduced in pulmonary artery smooth muscle cells (PASMCs) from MCT-treated rats. As a consequence of impaired BMP/Smad signaling, PASMCs from MCT-treated rats were resistant to apoptosis induced by BMP-4 and BMP-7, and were also resistant to BMP-4 antagonism of proliferation induced by platelet-derived growth factor.

Conclusion - BMP signaling and BMP-regulated physiological phenomena are perturbed in MCT-treated rats, lending solid support to the proposed roles for BMP signaling in the pathogenesis of human PAH.




Citation Styles

Harvard Citation styleMorty, R., Nejman, B., Kwapiszewska, G., Hecker, M., Zakrzewicz, A., Kouri, F., et al. (2007) Dysregulated bone morphogenetic protein signaling in monocrotaline-induced pulmonary arterial hypertension, Arteriosclerosis, Thrombosis, and Vascular Biology, 27(5), pp. 1072-1078. https://doi.org/10.1161/ATVBAHA.107.141200

APA Citation styleMorty, R., Nejman, B., Kwapiszewska, G., Hecker, M., Zakrzewicz, A., Kouri, F., Peters, D., Dumitrascu, R., Seeger, W., Knaus, P., Schermuly, R., & Eickelberg, O. (2007). Dysregulated bone morphogenetic protein signaling in monocrotaline-induced pulmonary arterial hypertension. Arteriosclerosis, Thrombosis, and Vascular Biology. 27(5), 1072-1078. https://doi.org/10.1161/ATVBAHA.107.141200



Keywords


bone morphogenetic proteinsGERMLINE MUTATIONSMONOCROTALINEMUSCLE-CELLSpulmonary arterial hypertensionSmadSMOOTHvascular remodelingVSMC proliferation

Last updated on 2025-21-05 at 18:44